Augment Investments has announced to acquire additional 10.032% stake in Pharmstandard OJSC, from Bristley Enterprises, to become a 79.8% stake holder in the company, upon the completion of the transaction.
According to the transaction, Augment will hold 15.2m global depository receipts (GDS) of Pharmstandard.
Pharmaceutical company Recordati S.p.A has invested $144.6m to acquire 100% share capital of Italchimici S.p.A.
The company expects that the acquisition will help expand its gastroenterology products, as well as strengthen its portfolio.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData